Comparison of survival outcomes of patients with newly diagnosed glioblastoma treated with standard chemoradiation in and outside of clinical trials

被引：0
|
作者：
Rahman, Rifaquat
Youssef, Gilbert
Ventz, Steffen
Redd, Robert
McDunn, Jon
Louv, William
Alexander, Brian Michael
Wen, Patrick Y.
Trippa, Lorenzo
机构：
[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Dana Farber Canc Inst, Brookline, MA USA
[4] Project Data Sphere, Morrisville, NC USA
[5] Project Data Sphere, Cary, NC USA
[6] Dana Farber Canc Inst Brigham & Womens Hosp, Boston, MA USA
[7] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[8] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CLINICAL IMPACT OF ADDING PEMBROLIZUMAB TO STANDARD OF CARE CHEMORADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ambady, Prakash
    Barajas, Ramon
    Fu, Rochelle
    Szidonya, Laszlo
    Huddleston, Amy
    Popp, Lauren
    Moussalli, Dana
    Turchan, Maria
    Diaz, Claire
    Edward, Neuwelt
    NEURO-ONCOLOGY, 2023, 25
  • [2] OVERALL SURVIVAL OF NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED BY STANDARD THERAPY IN COMPARISON TO STANDARD THERAPY PLUS TUMOR TREATING FIELDS
    Rulseh, Aaron
    Derner, Adam
    Sroubek, Jan
    Klener, Jan
    Vymazal, Josef
    NEURO-ONCOLOGY, 2020, 22 : 59 - 59
  • [3] Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma
    Vaugier, Loig
    Ah-Thiane, Loic
    Aumont, Maud
    Jouglar, Emmanuel
    Campone, Mario
    Colliard, Camille
    Doucet, Ludovic
    Frenel, Jean-Sebastien
    Gourmelon, Carole
    Robert, Marie
    Martin, Stephane-Andre
    Riem, Tanguy
    Roualdes, Vincent
    Campion, Loic
    Mervoyer, Augustin
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma
    Loïg Vaugier
    Loïc Ah-Thiane
    Maud Aumont
    Emmanuel Jouglar
    Mario Campone
    Camille Colliard
    Ludovic Doucet
    Jean-Sébastien Frenel
    Carole Gourmelon
    Marie Robert
    Stéphane-André Martin
    Tanguy Riem
    Vincent Roualdes
    Loïc Campion
    Augustin Mervoyer
    Scientific Reports, 11
  • [5] The role of neoadjuvant clinical trials in patients with newly diagnosed glioblastoma
    Bazer, Danielle A.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation
    Pinho, Marco C.
    Polaskova, Pavlina
    Kalpathy-Cramer, Jayashree
    Jennings, Dominique
    Emblem, Kyrre E.
    Jain, Rakesh K.
    Rosen, Bruce R.
    Wen, Patrick Y.
    Sorensen, A. Gregory
    Batchelor, Tracy T.
    Gerstner, Elizabeth R.
    ONCOLOGIST, 2014, 19 (01): : 75 - 81
  • [7] The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
    Han, Seunggu J.
    Rutledge, W. Caleb
    Molinaro, Annette M.
    Chang, Susan M.
    Clarke, Jennifer L.
    Prados, Michael D.
    Taylor, Jennie W.
    Berger, Mitchel S.
    Butowski, Nicholas A.
    NEUROSURGERY, 2015, 77 (02) : 248 - 253
  • [8] Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide
    Guler, Ozan Cem
    Yildirim, Berna Akkus
    Onal, Cem
    Topkan, Erkan
    INDIAN JOURNAL OF CANCER, 2019, 56 (01) : 59 - 64
  • [9] A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
    Nabors, Louis B.
    Fiveash, John B.
    Markert, James M.
    Kekan, Manasi S.
    Gillespie, George Y.
    Huang, Zhi
    Johnson, Martin J.
    Meleth, Sreelatha
    Kuo, Huichien
    Gladson, Candece L.
    Fathallah-Shaykh, Hassan M.
    ARCHIVES OF NEUROLOGY, 2010, 67 (03) : 313 - 319
  • [10] SOCIOECONOMIC FACTORS INFLUENCE OVERALL SURVIVAL IN CHEMORADIATION-TREATED NEWLY DIAGNOSED WHO GRADE 4 GLIOBLASTOMA
    Dada, Abraham
    Mehari, Mulki
    Kabir, Aymen
    Aabedi, Alexander
    Ore, Cecilia Dalle
    Hervey-Jumper, Shawn
    NEURO-ONCOLOGY, 2024, 26
12345